Metropolitan Life Insurance Company (MetLife)’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-24,821
| Closed | -$468K | – | 2612 |
|
|
2019
Q3 | $468K | Buy |
24,821
+2,424
| +11% | +$27.7K | 0.01% | 1338 |
|
|
2019
Q2 | $264K | Buy |
22,397
+2,003
| +10% | +$24.3K | ﹤0.01% | 1711 |
|
|
2019
Q1 | $278K | Sell |
20,394
-1,123
| -5% | -$14.5K | 0.01% | 1674 |
|
|
2018
Q4 | $221K | Hold |
21,517
| – | – | ﹤0.01% | 1749 |
|
|
2018
Q3 | $358K | Hold |
21,517
| – | – | 0.01% | 1604 |
|
|
2018
Q2 | $340K | Hold |
21,517
| – | – | 0.01% | 1572 |
|
|
2018
Q1 | $273K | Buy |
21,517
+1,560
| +8% | +$22.6K | ﹤0.01% | 1684 |
|
|
2017
Q4 | $229K | Sell |
19,957
-24,289
| -55% | -$271K | ﹤0.01% | 1833 |
|
|
2017
Q3 | $542K | Buy |
44,246
+11,082
| +33% | +$116K | ﹤0.01% | 1647 |
|
|
2017
Q2 | $380K | Hold |
33,164
| – | – | ﹤0.01% | 1897 |
|
|
2017
Q1 | $690K | Sell |
33,164
-1,249
| -4% | -$27.6K | ﹤0.01% | 1437 |
|
|
2016
Q4 | $716K | Hold |
34,413
| – | – | 0.01% | 1503 |
|
|
2016
Q3 | $1.13M | Hold |
34,413
| – | – | 0.01% | 1218 |
|
|
2016
Q2 | $859K | Buy |
34,413
+17,890
| +108% | +$484K | 0.01% | 1346 |
|
|
2016
Q1 | $405K | Hold |
16,523
| – | – | ﹤0.01% | 1717 |
|
|
2015
Q4 | $546K | Hold |
16,523
| – | – | ﹤0.01% | 1573 |
|
|
2015
Q3 | $541K | Buy |
16,523
+1,962
| +13% | +$83.4K | ﹤0.01% | 1587 |
|
|
2015
Q2 | $771K | Buy |
+14,561
| New | +$530K | 0.01% | 1462 |
|
|
2015
Q1 | – | Sell |
-6,911
| Closed | -$201K | – | 2537 |
|
|
2014
Q4 | $201K | Buy |
+6,911
| New | +$124K | ﹤0.01% | 2412 |
|
Metropolitan Life Insurance Company (MetLife)'s ALDR Position: Q4 2019 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 24,821 shares — an estimated $468K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in ALDR in Q4 2014 and held it in 19 quarters. The position peaked at $1.13M in Q3 2016. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 24,821 Alder Biopharmaceuticals shares in Q4 2019, an estimated $468K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Alder Biopharmaceuticals in Q4 2014 and held it in 19 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Alder Biopharmaceuticals position peaked at $1.13M in Q3 2016.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2019, filed 14 Feb 2020.